Shenyang Xingqi Pharmaceutical Co.,Ltd (SZSE:300573) entered into an equity transfer agreement to acquire additional 15.8% stake in Shenyang Xingqi Eye Hospital Co., Ltd. from Ningbo Meishan Bonded Port Area Zhensheng Investment Center (limited partnership) for CNY 0 on January 25, 2019. Under the terms, Shenyang Xingqi Pharmaceutical and Ningbo Meishan Bonded agree that although the Shenyang Xingqi Eye Hospital has opened but has no large-scale operating income, the operation is still in a loss state and Ningbo Meishan Bonded Port Area Zhensheng Investment Center has not invested in the underlying equity but Shenyang Xingqi Pharmaceutical shall bear the capital contribution obligation of CNY 7.9 million of the Shenyang Xingqi Eye Hospital equity and Shenyang Xingqi Pharmaceutical shall fulfill the capital contribution obligation in accordance with the provisions of the Shenyang Xingqi Eye Hospital 's articles of association. After the transaction, Shenyang Xingqi Pharmaceutical will increase the shareholding from 51% to 66.8% and Ningbo Meishan Bonded Port Area Zhensheng Investment Center (limited partnership) will decrease from 49% to 33.2% in Shenyang Xingqi Eye Hospital. Shenyang Xingqi Eye Hospital reported net assets of CNY 22.2 million and total assets of CNY 28.5 million as of September 30, 2018. The transaction was approved by the Board of Directors of Shenyang Xingqi Eye Hospital at 10th meeting of the 3rd directorate. Shenyang Xingqi Pharmaceutical Co.,Ltd (SZSE:300573) cancelled the acquisition of additional 15.8% stake in Shenyang Xingqi Eye Hospital Co., Ltd. from Ningbo Meishan Bonded Port Area Zhensheng Investment Center (limited partnership) on January 25, 2020.